We show that CD19 is indeed expressed on a substantial fraction of myeloma cells at ultra-low density in the majority of patients, and demonstrate that <100 CD19 molecules per myeloma cell trigger elimination by CD19 CAR-T. The gene discussed is CD19; the disease is plasma cell myeloma.